← United States · Coverage record
US · SEC FORM 4
GILEAD SCIENCES, INC.
GILD · Nasdaq · CIK 0000882095 · Healthcare · Drug Manufacturers—General
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
86 Form 4 transaction lines observed in the same window
44 sales · 42 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 21,828,725
- Previous report
- 18,304,875
- Avg daily volume
- 6,503,853
- Days to cover
- 3.4
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
No qualifying code P equity purchase is present in the local Form 4 history.
Form 4 evidence
163 transaction lines in the latest 365-day window; 759 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Mercier Johanna | Sale (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC filing ↗ |
| 2026-10-15 | Dickinson Andrew D | Sale (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC filing ↗ |
| 2026-10-01 | O'Day Daniel Patrick | Sale (S) | Common Stock | 15,000 | USD 147.90 | USD 2,218,508 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Mercier Johanna | Sale (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC filing ↗ |
| 2026-10-15 | Dickinson Andrew D | Sale (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC filing ↗ |
| 2026-10-01 | O'Day Daniel Patrick | Sale (S) | Common Stock | 15,000 | USD 147.90 | USD 2,218,508 | SEC filing ↗ |
| 2026-09-22 | Burkhart Erin | Option exercise / conversion (M) | Common Stock | 2,223 | USD — | USD — | SEC filing ↗ |
| 2026-09-22 | Burkhart Erin | Tax withholding (F) | Common Stock | 768 | USD 152.67 | USD 117,251 | SEC filing ↗ |
| 2026-09-15 | Mercier Johanna | Sale (S) | Common Stock | 3,000 | USD 144.22 | USD 432,646 | SEC filing ↗ |
| 2026-09-15 | Dickinson Andrew D | Sale (S) | Common Stock | 3,000 | USD 145.29 | USD 435,870 | SEC filing ↗ |
| 2026-09-10 | O'Day Daniel Patrick | Option exercise / conversion (M) | Common Stock | 8,780 | USD — | USD — | SEC filing ↗ |
| 2026-09-10 | O'Day Daniel Patrick | Tax withholding (F) | Common Stock | 4,230 | USD 144.81 | USD 612,546 | SEC filing ↗ |
| 2026-09-10 | Mercier Johanna | Option exercise / conversion (M) | Common Stock | 2,797 | USD — | USD — | SEC filing ↗ |
| 2026-09-10 | Mercier Johanna | Tax withholding (F) | Common Stock | 1,347 | USD 144.81 | USD 195,059 | SEC filing ↗ |
| 2026-09-10 | Dickinson Andrew D | Option exercise / conversion (M) | Common Stock | 2,797 | USD — | USD — | SEC filing ↗ |
| 2026-09-10 | Dickinson Andrew D | Tax withholding (F) | Common Stock | 1,347 | USD 144.81 | USD 195,059 | SEC filing ↗ |
| 2026-09-10 | Cain Wettan Keeley M | Option exercise / conversion (M) | Common Stock | 590 | USD — | USD — | SEC filing ↗ |
| 2026-09-10 | Cain Wettan Keeley M | Tax withholding (F) | Common Stock | 285 | USD 144.81 | USD 41,271 | SEC filing ↗ |
| 2026-09-10 | Berger Dietmar | Option exercise / conversion (M) | Common Stock | 533 | USD — | USD — | SEC filing ↗ |
| 2026-09-10 | Berger Dietmar | Tax withholding (F) | Common Stock | 263 | USD 144.81 | USD 38,085 | SEC filing ↗ |
| 2026-09-01 | O'Day Daniel Patrick | Sale (S) | Common Stock | 15,000 | USD 148.64 | USD 2,229,556 | SEC filing ↗ |
| 2026-08-26 | WELTERS ANTHONY | Sale (S) | Common Stock | 18,000 | USD 148.62 | USD 2,675,197 | SEC filing ↗ |
| 2026-08-26 | WELTERS ANTHONY | Option exercise / conversion (M) | Common Stock | 18,000 | USD 61.06 | USD 1,099,052 | SEC filing ↗ |
| 2026-08-20 | Bluestone Jeffrey | Sale (S) | Common Stock | 5,000 | USD 145.01 | USD 725,066 | SEC filing ↗ |
| 2026-08-20 | Bluestone Jeffrey | Option exercise / conversion (M) | Common Stock | 5,000 | USD 67.04 | USD 335,206 | SEC filing ↗ |
| 2026-08-17 | Mercier Johanna | Sale (S) | Common Stock | 28,000 | USD 137.64 | USD 3,854,045 | SEC filing ↗ |
| 2026-08-17 | Mercier Johanna | Option exercise / conversion (M) | Common Stock | 25,000 | USD 67.07 | USD 1,676,773 | SEC filing ↗ |
| 2026-08-17 | Dickinson Andrew D | Sale (S) | Common Stock | 3,000 | USD 138.36 | USD 415,080 | SEC filing ↗ |
| 2026-08-10 | Cain Wettan Keeley M | Option exercise / conversion (M) | Common Stock | 6,002 | USD — | USD — | SEC filing ↗ |
| 2026-08-10 | Cain Wettan Keeley M | Tax withholding (F) | Common Stock | 2,908 | USD 133.06 | USD 386,938 | SEC filing ↗ |
| 2026-08-03 | O'Day Daniel Patrick | Sale (S) | Common Stock | 15,000 | USD 130.31 | USD 1,954,686 | SEC filing ↗ |
| 2026-07-15 | Mercier Johanna | Sale (S) | Common Stock | 3,000 | USD 129.92 | USD 389,760 | SEC filing ↗ |
| 2026-07-15 | Dickinson Andrew D | Sale (S) | Common Stock | 3,000 | USD 129.93 | USD 389,790 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | GILD |
| CIK | 0000882095 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 759 transaction lines from 2020-01-03 to 2026-10-15 0 P purchase lines · 179 S sale lines · 580 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.